Forecast & Rating4 analysts currently cover ARS Pharmaceuticals, of which 4 give a positive rating. The average price target is $22.50, about 405.6% upside from the current price of $4.45. Coverage is limited, so the data is for reference only. Data as of Sep 18, 2026; this does not constitute investment advice.
Sep 18, 2026Price forecast
$22.50405.62%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 21, 2026
Forecast met24.4%
Stock price$4.45
Avg. target$22.5
High target$30
Low target$15
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.